1.90
+0.02(+1.06%)
Currency In USD
| Previous Close | 1.88 |
| Open | 1.9 |
| Day High | 1.95 |
| Day Low | 1.86 |
| 52-Week High | 15.25 |
| 52-Week Low | 1.34 |
| Volume | 228,177 |
| Average Volume | 259,614 |
| Market Cap | 95.27M |
| PE | -0.88 |
| EPS | -2.15 |
| Moving Average 50 Days | 1.88 |
| Moving Average 200 Days | 1.84 |
| Change | 0.02 |
If you invested $1000 in HilleVax, Inc. (HLVX) since IPO date, it would be worth $99.53 as of June 25, 2025 at a share price of $1.9. Whereas If you bought $1000 worth of HilleVax, Inc. (HLVX) shares 2 years ago, it would be worth $113.98 as of June 25, 2025 at a share price of $1.9.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
GlobeNewswire Inc.
May 08, 2025 11:00 AM GMT
$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025 The company is exploring the potential for continued development of its norovirus vaccine candidates inadults as well as business development related activities a
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
GlobeNewswire Inc.
Mar 28, 2025 9:00 PM GMT
$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business development related activiti
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
GlobeNewswire Inc.
Nov 07, 2024 1:00 PM GMT
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business development related activit